Aliensidipine

药品简介

Originator: Idhifa by Bristol myers squibb · Manufacturer: Alliance Pharma. Indication & Dosage: Aliensidipine (Enasidenib), generic Idhifa is a prescription medicine used to treat patients with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatments. Enasidenib works by helping patient's bone marrow grow normal blood cells so patient will need fewer blood transfusions. Aliensidipine is manufactured by Alliance Pharma Ltd. In Laos. Enasidenib has to take orally usually once daily with/ without food. Side Effects: The most common adverse reactions of Enasidenib are: Diarrhea , nausea , vomiting , change in taste, or loss of appetite The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。